{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:50:32Z","timestamp":1790895032362,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.vaccine.2008.07.057","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T21:14:07Z","timestamp":1218662047000},"page":"5246-5254","source":"Crossref","is-referenced-by-count":123,"title":["Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates"],"prefix":"10.1016","volume":"26","author":[{"given":"Igor S.","family":"Lukashevich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Ricardo","family":"Carrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.","family":"Salvato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Brasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Goicochea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gia E.","family":"Hoosien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anysha","family":"Ticer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Hammamieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mayda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marti","family":"Jett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"July (4)","key":"10.1016\/j.vaccine.2008.07.057_bib1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4269\/ajtmh.1970.19.670","article-title":"Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings","volume":"19","author":"Frame","year":"1970","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.07.057_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.185.4147.263","article-title":"Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone","volume":"185","author":"Monath","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2008.07.057_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2007.11.003","article-title":"New opportunities for field research on the pathogenesis and treatment of Lassa fever","volume":"78","author":"Khan","year":"2008","journal-title":"Antivir Res"},{"key":"10.1016\/j.vaccine.2008.07.057_bib4","first-page":"75","article-title":"Lassa fever","volume":"262","author":"McCormick","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib5","first-page":"86","article-title":"Update on Lassa fever in West Africa","volume":"80","author":"Anonymous: WHO","year":"2005","journal-title":"Weekly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2008.07.057_bib6","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","article-title":"Lassa fever: epidemiology, clinical features, and social consequences","volume":"327","author":"Richmond","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2008.07.057_bib7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3201\/eid1205.050052","article-title":"Historical Lassa fevers reports and 30-year clinical update","volume":"12","author":"Macher","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2008.07.057_bib8","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.07.057_bib9","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1128\/JVI.74.15.6777-6783.2000","article-title":"Effective vaccine for Lassa fever","volume":"74","author":"Fisher-Hoch","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1586\/14760584.3.2.189","article-title":"Lassa fever vaccine","volume":"3","author":"Fisher-Hoch","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2008.07.057_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01310811","article-title":"Ribonucleic acids of Machupo and Lassa viruses","volume":"79","author":"Lukashevich","year":"1984","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2174\/138920206778948673","article-title":"Lassa virus genome","volume":"7","author":"Lukashevich","year":"2006","journal-title":"Curr Genom"},{"key":"10.1016\/j.vaccine.2008.07.057_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1099\/0022-1317-78-3-547","article-title":"The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250kDa protein with monospecific antiserum","volume":"78","author":"Lukashevich","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1006\/viro.1997.8722","article-title":"Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5\u2032 end","volume":"235","author":"Djavani","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.07.057_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0042-6822(86)90438-1","article-title":"Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA","volume":"154","author":"Auperin","year":"1986","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.07.057_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0168-1702(91)90015-N","article-title":"Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products","volume":"18","author":"Clegg","year":"1991","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2008.07.057_bib17","doi-asserted-by":"crossref","first-page":"12701","DOI":"10.1073\/pnas.221447598","article-title":"The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1\/S1P.","volume":"98","author":"Lenz","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2008.07.057_bib18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0042-6822(92)90514-P","article-title":"Generation of reassortants between African arenaviruses","volume":"188","author":"Lukashevich","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.07.057_bib19","doi-asserted-by":"crossref","first-page":"13934","DOI":"10.1128\/JVI.79.22.13934-13942.2005","article-title":"A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses","volume":"79","author":"Lukashevich","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11262-006-0050-3","article-title":"Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses","volume":"34","author":"Moshkoff","year":"2007","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2008.07.057_bib21","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1016\/j.vaccine.2007.02.038","article-title":"A ML29 reassortant virus protects guinea pigs against a distantly-related Nigerian strain of Lassa virus and can provide sterilizing immunity","volume":"25","author":"Carrion","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.057_bib22","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1128\/JVI.02876-06","article-title":"Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues","volume":"81","author":"Carrion","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib23","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/JVI.77.3.1727-1737.2003","article-title":"Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation","volume":"77","author":"Lukashevich","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib24","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1099\/vir.0.80036-0","article-title":"GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology","volume":"85","author":"Jacob","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jmv.2206","article-title":"Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus","volume":"67","author":"Lukashevich","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib26","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1128\/JCM.32.12.2898-2903.1994","article-title":"Early diagnosis of Lassa fever by reverse transcription-PCR","volume":"32","author":"Demby","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-4-82","article-title":"Blood genomic profiles of exposures to Venezuelan equine encephalitis in cynomolgus macaques (Macaca fascicularis)","volume":"4","author":"Hammamieh","year":"2007","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2008.07.057_bib28","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.1128\/JVI.00536-07","article-title":"Early blood profiles of virus infection in a monkey model for Lassa fever","volume":"81","author":"Djavani","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4269\/ajtmh.1986.35.401","article-title":"Lassa virus hepatitis: a study of fatal Lassa fever in humans","volume":"35","author":"McCormick","year":"1986","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.07.057_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.virol.2003.12.013","article-title":"Old and new world arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones","volume":"321","author":"Meulen","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.07.057_bib31","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1128\/JVI.74.5.2186-2192.2000","article-title":"Characterization of human CD4+ T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein","volume":"74","author":"ter Meulen","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00100-08","article-title":"Basolateral entry and release of new and old world arenaviruses from human airway epithelia","author":"Dylla","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(90)90096-5","article-title":"Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine","volume":"8","author":"Saluzzo","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.057_bib34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1099\/vir.0.81184-0","article-title":"Very virulent infectious bursal disease virus: reduced pathogenicity in a rare natural segment-B-reassorted isolate","volume":"87","author":"Le Nou\u00ebn","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4065\/83.1.77","article-title":"Flu myths: dispelling the myths associated with live attenuated influenza vaccine","volume":"83","author":"Tosh","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.vaccine.2008.07.057_bib36","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1128\/JVI.75.23.11677-11685.2001","article-title":"Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses","volume":"75","author":"Pushko","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.07.057_bib37","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2008.07.057_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.virol.2005.12.001","article-title":"A recombinant Yellow fever 17D vaccine expressing Lassa virus glycoproteins","volume":"345","author":"Bredenbeek","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.07.057_bib39","unstructured":"Abakaliki D. Lassa fever kills two doctors in Ebonyl. allAfricacom 2008, http:\/\/allafrica.com\/stories\/200803210439.html."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08010062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08010062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T17:42:32Z","timestamp":1588873352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08010062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":39,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0264410X08010062"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.07.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}